Are myeloid microvesicles a marker and therapeutic target for neuroinflammation?
These findings identify myeloid MVs as a marker and therapeutic target of brain inflammation.
Longitudinal gene expression profiling of peripheral blood mononuclear cells from patients with acute HIV-1 infection can be used to create transcriptional network models to early predict viral set point with a high degree of accuracy.